Propranolol

matrix metallopeptidase 9 ; Homo sapiens







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30130526 Propranolol inhibits proliferation and invasion of hemangioma-derived endothelial cells by suppressing the DLL4/Notch1/Akt pathway. 2018 Oct 1 1
2 25728347 Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway. 2015 Aug 1
3 26622443 Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9. 2015 Sep 2
4 26665926 [Effect of propranolol gel on plasma VEGF, bFGF and MMP-9 in proliferating infantile hemangiomas of superficial type]. 2015 Jul 1
5 24135743 Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. 2013 Oct 6
6 22259987 [The change of serum vascular endothelial growth factor and matrix metalloproteinases-9 in proliferative hemangioma treated with propranolol]. 2011 Sep 1
7 20117846 Propranolol therapy for infantile haemangiomas: review of the literature. 2010 Apr 1
8 21042766 The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling. 2010 Dec 1
9 21124749 Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells. 2010 Nov 15 3
10 19467330 Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. 2009 Nov 3
11 17079456 Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells. 2006 Nov 1 1